These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21062767)

  • 1. Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies.
    Pons D; Trompet S; de Craen AJ; Thijssen PE; Quax PH; de Vries MR; Wierda RJ; van den Elsen PJ; Monraats PS; Ewing MM; Heijmans BT; Slagboom PE; Zwinderman AH; Doevendans PA; Tio RA; de Winter RJ; de Maat MP; Iakoubova OA; Sattar N; Shepherd J; Westendorp RG; Jukema JW; ; ;
    Heart; 2011 Jan; 97(2):143-50. PubMed ID: 21062767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of working memory but not in anxiety or stress response in p300/CBP associated factor (PCAF) histone acetylase knockout mice bred on a C57BL/6 background.
    Duclot F; Jacquet C; Gongora C; Maurice T
    Neurosci Lett; 2010 May; 475(3):179-83. PubMed ID: 20371377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
    Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
    Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
    Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
    Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple lysine methylation of PCAF by Set9 methyltransferase.
    Masatsugu T; Yamamoto K
    Biochem Biophys Res Commun; 2009 Mar; 381(1):22-6. PubMed ID: 19351588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation.
    Masumi A; Fukazawa H; Shimazu T; Yoshida M; Ozato K; Komuro K; Yamaguchi K
    Oncogene; 2006 Aug; 25(37):5113-24. PubMed ID: 16582966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
    Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
    Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F;
    Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1.
    Liu C; Lu J; Tan J; Li L; Huang B
    Cytokine; 2004 Aug 21-Sep 7; 27(4-5):93-100. PubMed ID: 15271374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease.
    Asselbergs FW; Pai JK; Rexrode KM; Hunter DJ; Rimm EB
    Clin Sci (Lond); 2007 Mar; 112(5):291-8. PubMed ID: 17040205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
    Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.
    Sie MP; Sayed-Tabatabaei FA; Oei HH; Uitterlinden AG; Pols HA; Hofman A; van Duijn CM; Witteman JC
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):212-7. PubMed ID: 16269662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.
    Rudez G; Pons D; Leebeek F; Monraats P; Schrevel M; Zwinderman A; de Winter R; Tio R; Doevendans P; Jukema W; de Maat M
    Hum Mutat; 2008 Mar; 29(3):375-80. PubMed ID: 18175333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart disease.
    Tasic I; Milojkovic M; Sunder-Plassmann R; Lazarevic G; Tasic NM; Stefanovic V
    Clin Chim Acta; 2007 Feb; 377(1-2):237-42. PubMed ID: 17129580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface: the genetics and epigenetics of addiction.
    Pollock JD; Ramaswami M
    J Neurogenet; 2009; 23(3):251. PubMed ID: 19194816
    [No Abstract]   [Full Text] [Related]  

  • 19. Neighborhood-specific epigenome analysis: the pathway forward to understanding gene-environment interactions.
    Olden K; Isaac L; Roberts L
    N C Med J; 2011; 72(2):125-7. PubMed ID: 21721498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral epigenetics: a new frontier in the study of hormones and behavior.
    Champagne FA; Rissman EF
    Horm Behav; 2011 Mar; 59(3):277-8. PubMed ID: 21419246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.